Asked by: Wendy Morton (Conservative - Aldridge-Brownhills)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to HCWS1271 on Improving Cancer Care and Early Diagnosis, which early cancer detection technologies NICE is currently assessing; what timelines apply to NICE's decisions to approve those technologies; whether funding has been allocated to adoption of approved early cancer detection technologies; what steps he is taking to help ensure that there is equitable access to early cancer detection technologies across the regions; and what steps he is taking to help ensure that innovation in early cancer detection technologies does not widen health inequalities.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is currently assessing a number of technologies relevant to earlier cancer detection. These include capsule sponge tests to support detection of oesophageal cancer in primary care settings, and artificial intelligence (AI) tools to assist clinicians in identifying prostate and breast cancers from imaging. NICE is also considering potential evaluations, subject to evidence readiness and prioritisation, for technologies aimed at improving detection of endometrial cancer, and for AI-derived software to analyse chest x-rays for suspected lung cancer.
Timelines vary depending on the NICE programme through which a technology is assessed. For technologies evaluated through the Technology Appraisal programme, a positive recommendation creates a statutory funding requirement for National Health Service commissioners to make the treatment available within 90 days of final guidance publication.
NHS England is working closely with NICE and the Department to support the prioritisation for the Technology Appraisal programme. Should NICE recommend use after a Technology Appraisal, NHS England will support adoption and implementation through funding allocated across the multi-year Spending Review.
The Government is clear that innovation must narrow, not widen, health inequalities. Access to NICE-recommended technologies is a national entitlement, and where the statutory funding requirement applies it operates consistently across England, regardless of geography or care setting. NICE’s methods require consideration of equality impacts, and implementation support is designed to ensure that new detection technologies reach underserved groups and do not exacerbate existing disparities.
More broadly, the Government is taking a range of steps to ensure equitable access to earlier diagnosis. Our National Cancer Plan will drive up standards across England and tackle health inequalities head on. New cancer manuals will set out what good care looks like, with regional partnerships of health leaders and clinicians using data to drive improvements where services are falling short. The plan will also see new national standards, designed by clinicians, and better data, to inform and drive changes where they are most needed.
Asked by: Clive Jones (Liberal Democrat - Wokingham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to align NICE appraisal timelines, MHRA regulatory pathways and NHS commissioning decisions to support the delivery of personalised cancer medicines.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) aims to issue guidance on new medicines close to the time of licensing to ensure that patients benefit from rapid access to clinically and cost effective new medicines. The National Health Service in England is legally required to fund medicines recommended by NICE, normally within three months of final guidance, and cancer medicines are eligible for funding through the Cancer Drugs Fund from the point of a positive draft NICE recommendation, bringing forward patient access by up to five months.
Through the Life Sciences Sector Plan, we are improving alignment between Medicines and Healthcare products Regulatory Agency licensing and NICE guidance, helping medicines reach patients three to six months faster. This includes a coordinated pathway and integrated advice service for developers, launching in March 2026, to streamline regulatory and Health Technology Assessment processes and support timely patient access. The Life Sciences Sector Plan is published and available at the following link:
Asked by: Andrew Snowden (Conservative - Fylde)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks to patient safety arising from hospital records not being fully shared between different NHS trusts.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Appropriate information sharing is essential to delivering safe and effective health care. Improving this will enable enhanced quality of care and safety for patients and better informed clinical and care decision-making empowered by access to precise and comprehensive information.
NHS England has been supporting National Health Service trusts and foundation trusts in acquiring and developing the effectiveness of their electronic patient records and supporting them to reach an optimum level of digital maturity which will further reduce barriers to the sharing of information needed to treat patients.
By 2028, a new single patient record will end the need for patients to have to repeat their medical history when interacting with the NHS. By providing a complete, real-time view of patient information across regions and care settings, it will significantly improve clinical safety and performance.
Asked by: David Baines (Labour - St Helens North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the National Institute for Health and Care Excellence (NICE) is working with NHS England and other relevant bodies in the development and implementation of Modern Service Frameworks.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is supporting the development of the modern service frameworks. NICE is also represented on the National Quality Board, along with other arm’s length bodies, that oversees the development of the modern service frameworks.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of blood donations.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) is responsible for blood services in England and is delivering initiatives to increase blood donations. These include:
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps he has taken to digitise patients’ medical records.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
£1.9 billion has been invested to ensure all National Health Service trusts achieve baseline digital capability, and 95% of trusts will have implemented or upgraded their Electronic Patient Record system (EPR) by March 2026, with the remainder planning to implement after this.
Recent areas for focus have been EPR optimisation, working to improve functionality, efficiency and usability, and a new tiger team service in the Frontline Digitisation Support offer for 2025/26, which is available to provide trusts with rapid on-site support at critical points of their EPR journey. The team’s work will also inform practical guidance to help other trusts deploy successfully and realise the benefits of digitisation.
NHS England is continuing to conduct digital maturity assessments to support local systems and trusts to prioritise and plan local digital investment.
Asked by: Shivani Raja (Conservative - Leicester East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his department plans to issue guidance on the potential risks of genetic defects in children born from consanguineous relationships.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England has published training modules about close relative marriage and genetic risk for midwives and health visitors. The training modules have been published for health professionals to access and there are no plans to publish them more widely. There are no plans to issue public facing guidance.
Asked by: Lord Kamall (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, in the light of proposals to shift from analogue to digital announced in the 10-year Health Plan for England, what provisions will be established to ensure digital exclusion does not exacerbate any existing inequalities...
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
National Health Service organisations must ensure that all patients have equitable access to care, and that decisions or policies do not unfairly disadvantage people or lead to an increase in inequalities. All NHS organisations are legally obliged to not discriminate against patients or staff.
This means that a non-digital solution should be available for those patients who cannot or do not wish to engage digitally, and these non-digital routes must be available for all services provided by NHS organisations.
Aligned to the Equality Act 2010 and the Health and Social Care Act 2012, each 10-Year Health Plan policy, proposition, programme, proposal, or initiative in scope of public sector equality duties will undergo an Equality Impact Assessments and Equality and Healthcare Inequalities Impact Assessments.
Asked by: Scott Arthur (Labour - Edinburgh South West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of introducing the 2018 Nutrient Profiling Model on business investment in the food and drink sector.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
As set out in our 10-Year Health Plan for England: fit for the future, we will take decisive action on the obesity crisis, easing the strain on our National Health Service and creating the healthiest generation of children ever. As part of this, the Government committed to updating the standards behind the restrictions on advertising ‘less healthy’ food or drink products on television before 9:00pm and online at any time, as well as the restrictions on the promotion of ‘less healthy’ food and drink products by location and volume price by applying the new Nutrient Profiling Model (NPM).
The advertising and promotions restrictions currently rely on the outdated NPM 2004/05. The new NPM has been updated in line with the latest dietary advice from the United Kingdom’s Scientific Advisory Committee on Nutrition, particularly in relation to free sugar and fibre. Applying it to the restrictions will strengthen these policies by bringing more products of concern for children’s health into scope.
The Government published the new NPM on 27 January. Application of the new NPM to the advertising and promotions restrictions would be subject to a full public consultation and an impact assessment of the costs to businesses and intended health outcomes.
Asked by: Iqbal Mohamed (Independent - Dewsbury and Batley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he plans to take to ensure parliamentary oversight of the proposed changes to NICE regulations.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The proposed amendments to the National Institute for Health and Care Excellence regulations were subject to a public consultation, which ran from 9 December 2025 to 13 January 2026. The Department is currently analysing consultation responses and will shortly finalise a statutory instrument (SI) to bring forward secondary legislation to amend the regulations.
The SI will be laid before Parliament and will be subject to the negative parliamentary procedure. The policy merits of the SI will be scrutinised by the Secondary Legislation Scrutiny Committee, in line with its terms of reference at the following link:
As is conventional, the SI will be laid before Parliament at least 21 days before coming into force to ensure Parliament has adequate time to consider it.